|
1
|
Khan AS and Dageforde LA:
Cholangiocarcinoma. Surg Clin North Am. 99:315–335. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Buckholz AP and Brown RS Jr:
Cholangiocarcinoma: Diagnosis and management. Clin Liver Dis.
24:421–436. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dondossola D, Ghidini M, Grossi F, Rossi G
and Foschi D: Practical review for diagnosis and clinical
management of perihilar cholangiocarcinoma. World J Gastroenterol.
26:3542–3561. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Banales JM, Marin JJ, Lamarca A, Rodrigues
PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB,
Braconi C, et al: Cholangiocarcinoma 2020: The next horizon in
mechanisms and management. Nat Rev Gastroenterol Hepatol.
17:557–588. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK
and Gores GJ: Cholangiocarcinoma-evolving concepts and therapeutic
strategies. Nat Rev Clin Oncol. 15:95–111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Labib PL, Goodchild G and Pereira SP:
Molecular pathogenesis of cholangiocarcinoma. BMC Cancer.
19:1852019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang T, Chen G, Liu C, Zu L, Wang Q, Wang
Y, Lv J, An Y, Dong L, Cheng H, et al: A phase I Study comparing
the pharmacokinetics, safety, and immunogenicity of proposed
biosimilar GB242 and reference infliximab in healthy subjects.
BioDrugs. 33:93–100. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhai Y, Li N, Jiang H, Huang X, Gao N and
Tye BK: Unique roles of the non-identical MCM subunits in DNA
replication licensing. Mol Cell. 67:168–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhong X, Chen X, Guan X, Zhang H, Ma Y,
Zhang S, Wang E, Zhang L and Han Y: Overexpression of G9a and MCM7
in oesophageal squamous cell carcinoma is associated with poor
prognosis. Histopathology. 66:192–200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Das M, Prasad SB, Yadav SS, Govardhan HB,
Pandey LK, Singh S, Pradhan S and Narayan G: Over expression of
minichromosome maintenance genes is clinically correlated to
cervical carcinogenesis. PLoS One. 8:e696072013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giaginis C, Giagini A, Tsourouflis G,
Gatzidou E, Agapitos E, Kouraklis G and Theocharis S: MCM-2 and
MCM-5 expression in gastric adenocarcinoma: Clinical significance
and comparison with Ki-67 proliferative marker. Dig Dis Sci.
56:777–785. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cobanoglu U, Mungan S, Gundogdu C, Ersoz
S, Ozoran Y and Aydin F: The expression of MCM-2 in invasive breast
carcinoma: A stereologic approach. Bratisl Lek Listy. 111:45–49.
2010.PubMed/NCBI
|
|
13
|
Gozuacik D, Chami M, Lagorce D, Faivre J,
Murakami Y, Poch O, Biermann E, Knippers R, Bréchot C and
Paterlini-Bréchot P: Identification and functional characterization
of a new member of the human Mcm protein family: hMcm8. Nucleic
Acids Res. 31:570–579. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Z, Li J, Chen J, Shan Q, Dai H, Xie H,
Zhou L, Xu X and Zheng S: MCM family in HCC: MCM6 indicates adverse
tumor features and poor outcomes and promotes S/G2 cell cycle
progression. BMC Cancer. 18:2002018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haonon O, Rucksaken R, Pinlaor P,
Pairojkul C, Chamgramol Y, Intuyod K, Onsurathum S, Khuntikeo N and
Pinlaor S: Upregulation of 14-3-3 eta in chronic liver fluke
infection is a potential diagnostic marker of cholangiocarcinoma.
Proteomics Clin Appl. 10:248–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maiorano D, Cuvier O, Danis E and Méchali
M: MCM8 is an MCM2-7-related protein that functions as a DNA
helicase during replication elongation and not initiation. Cell.
120:315–328. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Volkening M and Hoffmann I: Involvement of
human MCM8 in prereplication complex assembly by recruiting hcdc6
to chromatin. Mol Cell Biol. 25:1560–1568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kotsantis P, Silva LM, Irmscher S, Jones
RM, Folkes L, Gromak N and Petermann E: Increased global
transcription activity as a mechanism of replication stress in
cancer. Nat Commun. 7:130872016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hills SA and Diffley JF: DNA replication
and oncogene-induced replicative stress. Curr Biol. 24:R435–R444.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He DM, Ren BG, Liu S, Tan LZ, Cieply K,
Tseng G, Yu YP and Luo JH: Oncogenic activity of amplified
miniature chromosome maintenance 8 in human malignancies. Oncogene.
36:3629–3639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peng YP, Zhu Y, Yin LD, Zhang JJ, Guo S,
Fu Y, Miao Y and Wei JS: The expression and prognostic roles of
MCMs in pancreatic cancer. PLoS One. 11:e01641502016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Song X, Liu X, Wang H, Wang J, Qiao Y,
Cigliano A, Utpatel K, Ribback S, Pilo MG, Serra M, et al: Combined
CDK4/6 and Pan-mTOR inhibition is synergistic against intrahepatic
cholangiocarcinoma. Clin Cancer Res. 25:403–413. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Samukawa E, Fujihara S, Oura K, Iwama H,
Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara
M, et al: Angiotensin receptor blocker telmisartan inhibits cell
proliferation and tumor growth of cholangiocarcinoma through cell
cycle arrest. Int J Oncol. 51:1674–1684. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Ji G, Han S, Shao Z, Lu Z, Huo L,
Zhang J, Yang R, Feng Q, Shen H, et al: Tip60 Suppresses
cholangiocarcinoma proliferation and metastasis via PI3k-AKT. Cell
Physiol Biochem. 50:612–628. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng R, Zhang PF, Zhang C, Huang XY, Ding
YB, Deng B, Bai DS and Xu YP: Elevated TRIM44 promotes intrahepatic
cholangiocarcinoma progression by inducing cell EMT via MAPK
signaling. Cancer Med. 7:796–808. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Liang Y, Yang G, Lan Y, Han J,
Wang J, Yin D, Song R, Zheng T, Zhang S, et al: Tetraspanin 1
promotes epithelial-to-mesenchymal transition and metastasis of
cholangiocarcinoma via PI3K/AKT signaling. J Exp Clin Cancer Res.
37:3002018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang W, Wang Y, Li W, Shi L and Geng Z:
MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma
by targeting Cyclin D1. J Cell Mol Med. 23:4945–4954. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kitchen P, Lee KY, Clark D, Lau N,
Lertsuwan J, Sawasdichai A, Satayavivad J, Oltean S, Afford S,
Gaston K and Jayaraman PS: A runaway PRH/HHEX-notch3-positive
feedback loop drives cholangiocarcinoma and determines response to
CDK4/6 inhibition. Cancer Res. 80:757–770. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang MX, Gan W, Jing CY, Zheng SS, Yi Y,
Zhang J, Xu X, Lin JJ, Zhang BH and Qiu SJ: S100A11 promotes cell
proliferation via P38/MAPK signaling pathway in intrahepatic
cholangiocarcinoma. Mol Carcinog. 58:19–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
